Company Profile

MERCURY LABORATORIES LTD.

NSE : NABSE : 538964ISIN CODE : INE947G01011Industry : Pharmaceuticals & DrugsHouse : Private
BSE660.0017.2 (+2.68 % )
PREV CLOSE (Rs.) 642.80
OPEN PRICE (Rs.) 670.00
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 542
TODAY'S LOW / HIGH (Rs.)615.20 761.00
52 WK LOW / HIGH (Rs.) 440.45 937
NSE
This Company is not listed in NSE

Smart Quotes

1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Trade Value (Rs. in Lacs) 3.5772
Dividend Yield(%)
TTM EPS (Rs.)
P/E Ratio
Book Value (Rs.)
Face Value (Rs.)
MCap (Rs. in Mn)
Price/Earning (TTM)
Price/Sales (TTM)
Price/Book (MRQ)
PAT Margin (%) 7.78
ROCE (%) 20.56
Incorporation Year : 1982

Management Info :

Divyakant R Zaveri - Chairman Rajendra R Shah - Managing Director

Registered Office :

Address : 18, Shreeji Bhuvan,51, Mangaldas Road,Princess Street,
Mumbai,
Maharashtra-400002

Phone : 022 - 6637 2841

Registrar's Details : Link Intime India Pvt Ltd.
B-102 & B103, Shangrila Complex, First Floor,Opp: HDFC Bank, Near Radhakrishna Char Rasta,Akota,Vadodara
Listing : BSE, OTCEI
NEWS More
07Dec12-07-2021$Mercury Laboratories informs about stop transfer request Mercury Laboratories informs

Mercury Laboratories has informed that the company received an information from shareholders by its RTA, Link Intime India pertaining to stop transfer request. Details of the same are attached.

The above information is a part of company’s filings submitted to BSE.

Mercury Laboratories has informed that the company received an..
25Nov11-25-2021$Mercury Laboratories informs about stop transfer request Mercury Laboratories informs

Mercury Laboratories has informed that it received the information from shareholders by its RTA, Link Intime India pertaining to stop transfer request. Details of the share certificate are enclosed.

The above information is a part of company’s filings submitted to BSE.


Mercury Laboratories has informed that it received the informat..
23Oct10-23-2021$Mercury Laboratories informs about press release Mercury Laboratories informs
Mercury Laboratories has informed that it attached newspaper cuttings for publication of Un-audited Standalone Financial Result for the quarter ended September 30, 2021 under Regulation 33 of SEBI (LODR), Regulations, 2015 published in newspapers viz. The Free Press (English) and Navshakti (Marathi).

The above information is a part of company’s filings submitted to BSE.

Mercury Laboratories has informed that it attached newspaper cu..
12Oct10-12-2021$ Board Meeting Intimation for Board Meeting Intimation For Board Of Directors Meeting To Be Held On October 21, 2021 Board Meeting Intimation fo
Mercury Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/10/2021 ,inter alia, to consider and approve 1. Un-audited financial results of the Company for the quarter ended on September 30, 2021 2. To consider and approve appointment of Mr. Ashish Vasavada as Chief Financial Officer of the company with the effect from October 21, 2021. 3. To consider and approve any other items of Agenda, if any The results so approved will be published pursuant to provisions of LODR. Further, as per the Company's Code of Conduct to Regulate, Monitor & Report Trading by Insider as per Code of Conduct for prevention of Insider Trading, framed pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015, the trading window for dealing in the securities of the Company shall remain closed till the completion of 48 hours after declaration of financial results at the Board Meeting for all the Directors/officers/Designated Persons of the Company & shall re-open from the start of the business hours on October 24, 2021. You are therefore requested to take the above information on records
Mercury Laboratories Ltdhas informed BSE that the meeting of th..
08Oct10-08-2021$Mercury Laboratories informs about stop transfer intimation Mercury Laboratories informs

Mercury Laboratories has informed that the company has received the information from shareholders by its RTA, Link Intime India pertaining to stop transfer request. Details regarding the share certificate are attached.

The above information is a part of company’s filings submitted to BSE.

Mercury Laboratories has informed that the company has received..
Financials More
Rs. in Millions
QTR Sep 21 ANNUAL 21
Net Profit9.6453.3800000000001
Gross Profit 14.1 79.1000000000001
Operating Profit 22.56104.72
Net Sales 134.73686.02
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group More
TTK Healthcare (BSE)
 770.00 (13.30%)
M.Cap ( in Cr)
1088.04
Ajanta Pharma (BSE)
 2132.05 (1.78%)
M.Cap ( in Cr)
18449.86
Natco Pharma (BSE)
 866.75 (3.88%)
M.Cap ( in Cr)
15804.13
Glaxosmithkline Phar (BSE)
 1876.00 (1.75%)
M.Cap ( in Cr)
31780.57
Gland Pharma (BSE)
 3561.00 (0.87%)
M.Cap ( in Cr)
58507.90
Shareholding Pattern More
PROMOTERS 73.66 %
NON-INSTITUTION 26.34 %
MUTUAL FUNDS/UTI 0 %
FI/BANKS/INSURANCE 0 %
GOVERNMENT 0 %
FII 0 %
MF HOLDINGS
Scheme NameHold(%)
No Data Found
F & O Quotes